Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab

the Japan Urological Oncology Group

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science